Function of Large and Small Platelets Differs, Depending on Extracellular Calcium Availability and Type of Inductor

Abstract

It is widely anticipated that large platelets are more reactive than small platelets. This was mainly shown in Ca²⁺-poor media albeit extracellular Ca²⁺ is utilized by platelets for activation. We determined the impact of extracellular Ca²⁺ on functional differences between large and small platelets in response to thrombin receptor activating peptide 6 (TRAP-6), adenosine diphosphate (ADP), and epinephrine. In Ca²⁺-poor buffer, large platelets responded stronger to TRAP-6 which equalized in Ca²⁺ containing buffer. Large platelets contained and mobilized more Ca²⁺ from their intracellular stores upon TRAP-6 stimulation explaining their better reactivity in Ca²⁺-poor media. Stronger aggregation of large platelets in response to ADP also equalized in presence of Ca²⁺, whereas large platelets responded weaker to ADP in flow cytometry (CD62P-expression: 9.7 mean fluorescence intensity [MFI] [4.4–17.9] vs. 17.5 MFI [6.1–45.6], p = 0.0234) and PAC-1 binding (11.1 MFI [5.7–19.6] vs. 20.5 MFI [14.4–35.0], p = 0.0078). Epinephrine response was stronger in large platelets (CD62P-expression: 11.8 MFI [6.8–33.0] vs. 6.8 MFI [2.5–15.2], p = 0.0078; PAC-1 binding 18.9 MFI [13.6–38.4] vs. 13.0 MFI [6.8–22.4], p = 0.0234; max. aggregation 82.9% [58.7–94.8] vs. 77.2% [19.8–88.8], p = 0.0313), which expressed more α2A receptors. Epinephrine further increased phosphatidylserine (PS) exposure especially in large platelets. PS-positive platelets progressively divided into two subpopulations with high or basic intracellular Ca²⁺ dependent on extracellular Ca²⁺. Thrombin generation was faster with small, but accelerated by PS exposure and epinephrine-coactivated large platelets. We show that responses of large and small platelets differ depending on extracellular Ca²⁺ availability and the inductor. Careful control of extracellular Ca²⁺ is necessary in functional studies with large and small platelets.

Keywords

blood platelets - adenosine diphosphate - TRAP peptide - epinephrine - calcium - phosphatidylserine - thrombin generation

Authors' Contributions

S.H. and T.T. designed the experiments; S.H., J.W., and R.P. performed the experiments; S.H., A.G., and T.T. analyzed the data; S.H., A.G., and T.T. wrote the manuscript. All authors contributed to manuscript revision, read and approved the submitted version.

• References

• 1 Topalov NN, Yakimenko AO, Canault M. , et al. Two types of procoagulant platelets are formed upon physiological activation and are controlled by integrin α(IIb)β(3). Arterioscler Thromb Vasc Biol 2012; 32 (10) 2475-2483
• 2 Abaeva AA, Canault M, Kotova YN. , et al. Procoagulant platelets form an α-granule protein-covered “cap” on their surface that promotes their attachment to aggregates. J Biol Chem 2013; 288 (41) 29621-29632
• 3 Podoplelova NA, Sveshnikova AN, Kotova YN. , et al. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting. Blood 2016; 128 (13) 1745-1755
• 4 Dale GL, Friese P, Batar P. , et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415 (6868): 175-179
• 5 Munnix IC, Cosemans JM, Auger JM, Heemskerk JW. Platelet response heterogeneity in thrombus formation. Thromb Haemost 2009; 102 (06) 1149-1156
• 6 McDonald TP, Odell Jr TT, Gosslee DG. Platelet size in relation to platelet age. Proc Soc Exp Biol Med 1964; 115: 684-689
• 7 Handtke S, Steil L, Greinacher A, Thiele T. Toward the relevance of platelet subpopulations for transfusion medicine. Front Med (Lausanne) 2018; 5: 17
• 8 Handtke S, Thiele T. Large and small platelets - (when) do they differ?. J Thromb Haemost 2020 Doi: 10.1111/jth.14788
• 9 Chu SG, Becker RC, Berger PB. , et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010; 8 (01) 148-156
• 10 Handtke S, Steil L, Palankar R. , et al. Role of platelet size revisited-function and protein composition of large and small platelets. Thromb Haemost 2019; 119 (03) 407-420
• 11 Karpatkin S. Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest 1969; 48 (06) 1083-1087
• 12 Karpatkin S. Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 1978; 51 (02) 307-316
• 13 Thompson CB, Jakubowski JA, Quinn PG, Deykin D, Valeri CR. Platelet size as a determinant of platelet function. J Lab Clin Med 1983; 101 (02) 205-213
• 14 Frojmovic M, Wong T. Dynamic measurements of the platelet membrane glycoprotein IIb-IIIa receptor for fibrinogen by flow cytometry. II. Platelet size-dependent subpopulations. Biophys J 1991; 59 (04) 828-837
• 15 Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003; 4 (07) 517-529
• 16 Varga-Szabo D, Braun A, Nieswandt B. STIM and Orai in platelet function. Cell Calcium 2011; 50 (03) 270-278
• 17 Corash L, Costa JL, Shafer B, Donlon JA, Murphy D. Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents. Blood 1984; 64 (01) 185-193
• 18 Chamberlain KG, Seth P, Jones MK, Penington DG. Subcellular composition of platelet density subpopulations prepared using continuous Percoll gradients. Br J Haematol 1989; 72 (02) 199-207
• 19 Greinacher A, Weitmann K, Schönborn L. , et al. A population-based longitudinal study on the implication of demographic changes on blood donation and transfusion demand. Blood Adv 2017; 1 (14) 867-874
• 20 Baaten CC, Moenen FC, Henskens YM. , et al. OC-08 - multiple functional defects in platelets from thrombocytopenic cancer patients undergoing chemotherapy. Thromb Res 2016; 140 (Suppl. 01) S171
• 21 Assinger A, Volf I, Schmid D. A novel, rapid method to quantify intraplatelet calcium dynamics by ratiometric flow cytometry. PLoS One 2015; 10 (04) e0122527
• 22 Cavallini L, Coassin M, Alexandre A. Two classes of agonist-sensitive Ca²⁺ stores in platelets, as identified by their differential sensitivity to 2,5-di-(tert-butyl)-1,4-benzohydroquinone and thapsigargin. Biochem J 1995; 310 (Pt 2): 449-452
• 23 Alberio L, Ravanat C, Hechler B, Mangin PH, Lanza F, Gachet C. Delayed-onset of procoagulant signalling revealed by kinetic analysis of COAT platelet formation. Thromb Haemost 2017; 117 (06) 1101-1114
• 24 Kahn ML, Zheng YW, Huang W. , et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394 (6694): 690-694
• 25 Mustard JF, Perry DW, Kinlough-Rathbone RL, Packham MA. Factors responsible for ADP-induced release reaction of human platelets. Am J Physiol 1975; 228 (06) 1757-1765
• 26 Smith TM, Kirley TL. The calcium activated nucleotidases: a diverse family of soluble and membrane associated nucleotide hydrolyzing enzymes. Purinergic Signal 2006; 2 (02) 327-333
• 27 Jones S, Evans RJ, Mahaut-Smith MP. Extracellular Ca(2+) modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation. Br J Haematol 2011; 153 (01) 83-91
• 28 Spalding A, Vaitkevicius H, Dill S, MacKenzie S, Schmaier A, Lockette W. Mechanism of epinephrine-induced platelet aggregation. Hypertension 1998; 31 (02) 603-607
• 29 Saeed SA, Rasheed H, Fecto FA. , et al. Signaling mechanisms mediated by G-protein coupled receptors in human platelets. Acta Pharmacol Sin 2004; 25 (07) 887-892
• 30 Ghilotti M, Lova P, Balduini C, Torti M. Epinephrine induces intracellular Ca²⁺ mobilization in thrombin-desensitized platelets: a role for GPIb-IX-V. Platelets 2007; 18 (02) 135-142
• 31 Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 2000; 95 (05) 1694-1702
• 32 Hua VM, Abeynaike L, Glaros E. , et al. Necrotic platelets provide a procoagulant surface during thrombosis. Blood 2015; 126 (26) 2852-2862
• 33 Lanza F, Beretz A, Stierlé A, Hanau D, Kubina M, Cazenave JP. Epinephrine potentiates human platelet activation but is not an aggregating agent. Am J Physiol 1988; 255 (6 Pt 2): H1276-H1288
• 34 Tait JF, Gibson D. Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content. Arch Biochem Biophys 1992; 298 (01) 187-191
• 35 Tait JF, Gibson DF, Smith C. Measurement of the affinity and cooperativity of annexin V-membrane binding under conditions of low membrane occupancy. Anal Biochem 2004; 329 (01) 112-119